Hypertension is associated with the reduction in epidermal small fibres independently of sural nerve inflammation in type 2 diabetic subjects

Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated w...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurochemistry Vol. 169; no. 2; pp. e16235 - n/a
Main Authors Wang, Zhenchao, Kushibiki, Hanae, Tarusawa, Takefusa, Osonoi, Sho, Ogasawara, Saori, Miura, Chinatsu, Sasaki, Takanori, Ryuzaki, Masaki, Yagihashi, Soroku, Mizukami, Hiroki
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.02.2025
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non‐diabetic patients (nDM), 11 non‐diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti‐CD68 and anti‐CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206−/CD68+ proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206+/CD68+ anti‐inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206− and CD206+ macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206+ macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = ‐0.59, p < 0.01) and MNFD (r =‐0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms. In this study, the effects of hypertension and local inflammation on the human diabetic peripheral nerve were assessed. Diabetic patients complicated with hypertension showed a marked decrease in intraepidermal and sural myelinated nerve fibre density. In diabetic sural nerves, hypertension had no impact on proinflammatory macrophage infiltration, which was inversely correlated with only myelinated nerve fibre density. On the other hand, the total diffusion barrier thickness of endoneurial vessels increased in hypertension patients, which was inversely correlated with both intraepidermal and myelinated nerve fibre density. Our results suggest that hypertension can exacerbate neuropathy in human diabetic patients independently of local inflammation.
AbstractList Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non-diabetic patients (nDM), 11 non-diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti-CD68 and anti-CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206 /CD68 proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206 /CD68 anti-inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206 and CD206 macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206 macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = -0.59, p < 0.01) and MNFD (r =-0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms.
Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non‐diabetic patients (nDM), 11 non‐diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti‐CD68 and anti‐CD206 antibodies. IENFD was significantly decreased in DM compared to nDM ( p < 0.05) and was further decreased in DMHT ( p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM ( p < 0.05) and further decreased in DMHT ( p < 0.01 vs. DM). The infiltration of CD206 − /CD68 + proinflammatory macrophages in the SN was significantly increased in DM compared to nDM ( p < 0.05), whilst the number of CD206 + /CD68 + anti‐inflammatory macrophages was decreased in DM ( p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206 − and CD206 + macrophage was negatively correlated with MNFD ( r = 0.42, p < 0.05) but not IENFD ( r = 0.30, p = 0.09). Dermal CD206 + macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness ( p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD ( r = ‐0.59, p < 0.01) and MNFD ( r =‐0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms. image
Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non‐diabetic patients (nDM), 11 non‐diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti‐CD68 and anti‐CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206−/CD68+ proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206+/CD68+ anti‐inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206− and CD206+ macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206+ macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = ‐0.59, p < 0.01) and MNFD (r =‐0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms.
Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non‐diabetic patients (nDM), 11 non‐diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti‐CD68 and anti‐CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206−/CD68+ proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206+/CD68+ anti‐inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206− and CD206+ macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206+ macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = ‐0.59, p < 0.01) and MNFD (r =‐0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms. In this study, the effects of hypertension and local inflammation on the human diabetic peripheral nerve were assessed. Diabetic patients complicated with hypertension showed a marked decrease in intraepidermal and sural myelinated nerve fibre density. In diabetic sural nerves, hypertension had no impact on proinflammatory macrophage infiltration, which was inversely correlated with only myelinated nerve fibre density. On the other hand, the total diffusion barrier thickness of endoneurial vessels increased in hypertension patients, which was inversely correlated with both intraepidermal and myelinated nerve fibre density. Our results suggest that hypertension can exacerbate neuropathy in human diabetic patients independently of local inflammation.
Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non-diabetic patients (nDM), 11 non-diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti-CD68 and anti-CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206-/CD68+ proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206+/CD68+ anti-inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206- and CD206+ macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206+ macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = -0.59, p < 0.01) and MNFD (r =-0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms.Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non-diabetic patients (nDM), 11 non-diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti-CD68 and anti-CD206 antibodies. IENFD was significantly decreased in DM compared to nDM (p < 0.05) and was further decreased in DMHT (p < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM (p < 0.05) and further decreased in DMHT (p < 0.01 vs. DM). The infiltration of CD206-/CD68+ proinflammatory macrophages in the SN was significantly increased in DM compared to nDM (p < 0.05), whilst the number of CD206+/CD68+ anti-inflammatory macrophages was decreased in DM (p < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206- and CD206+ macrophage was negatively correlated with MNFD (r = 0.42, p < 0.05) but not IENFD (r = 0.30, p = 0.09). Dermal CD206+ macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness (p < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD (r = -0.59, p < 0.01) and MNFD (r =-0.62, p < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms.
Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension. A close interaction between the immune system and hypertension is known. It remains unclear whether the inflammatory response is associated with hypertension in the pathology of human DPN. Autopsied patients were evaluated: 7 non‐diabetic patients (nDM), 11 non‐diabetic patients with hypertension (nDMHT), 6 patients with diabetes (DM) and 9 patients with hypertension and diabetes (DMHT). Intraepidermal nerve fibre density (IENFD) was examined by immunofluorescent staining. Dissected sural nerve (SNs) were morphometrically quantified. Dermal and endoneurial macrophage infiltration was evaluated by double immunostaining using anti‐CD68 and anti‐CD206 antibodies. IENFD was significantly decreased in DM compared to nDM ( p  < 0.05) and was further decreased in DMHT ( p  < 0.05). Myelinated nerve fibre density (MNFD) in the SN was significantly decreased in DM compared with nDM ( p  < 0.05) and further decreased in DMHT ( p  < 0.01 vs. DM). The infiltration of CD206 − /CD68 + proinflammatory macrophages in the SN was significantly increased in DM compared to nDM ( p  < 0.05), whilst the number of CD206 + /CD68 + anti‐inflammatory macrophages was decreased in DM ( p  < 0.05). Hypertension had no impact on macrophage infiltration. The ratio of CD206 − and CD206 + macrophage was negatively correlated with MNFD ( r  = 0.42, p  < 0.05) but not IENFD ( r  = 0.30, p  = 0.09). Dermal CD206 + macrophage infiltration was similar amongst all groups. Diabetes complicated by hypertension significantly increased the total diffusion barrier thickness ( p  < 0.01 vs. DM). Total diffusion barrier thickness was inversely correlated with both IENFD ( r  = ‐0.59, p  < 0.01) and MNFD ( r  =‐0.62, p  < 0.01). Our results suggest that vascular factors and inflammation might be synergistically involved in pathological changes in human diabetic patients through different mechanisms. In this study, the effects of hypertension and local inflammation on the human diabetic peripheral nerve were assessed. Diabetic patients complicated with hypertension showed a marked decrease in intraepidermal and sural myelinated nerve fibre density. In diabetic sural nerves, hypertension had no impact on proinflammatory macrophage infiltration, which was inversely correlated with only myelinated nerve fibre density. On the other hand, the total diffusion barrier thickness of endoneurial vessels increased in hypertension patients, which was inversely correlated with both intraepidermal and myelinated nerve fibre density. Our results suggest that hypertension can exacerbate neuropathy in human diabetic patients independently of local inflammation.
Author Wang, Zhenchao
Osonoi, Sho
Miura, Chinatsu
Yagihashi, Soroku
Ryuzaki, Masaki
Kushibiki, Hanae
Sasaki, Takanori
Tarusawa, Takefusa
Ogasawara, Saori
Mizukami, Hiroki
AuthorAffiliation 1 Department of Pathology and Molecular Medicine, Biomedical Research Center Hirosaki University Graduate School of Medicine Hirosaki Japan
AuthorAffiliation_xml – name: 1 Department of Pathology and Molecular Medicine, Biomedical Research Center Hirosaki University Graduate School of Medicine Hirosaki Japan
Author_xml – sequence: 1
  givenname: Zhenchao
  surname: Wang
  fullname: Wang, Zhenchao
  organization: Hirosaki University Graduate School of Medicine
– sequence: 2
  givenname: Hanae
  surname: Kushibiki
  fullname: Kushibiki, Hanae
  organization: Hirosaki University Graduate School of Medicine
– sequence: 3
  givenname: Takefusa
  surname: Tarusawa
  fullname: Tarusawa, Takefusa
  organization: Hirosaki University Graduate School of Medicine
– sequence: 4
  givenname: Sho
  surname: Osonoi
  fullname: Osonoi, Sho
  organization: Hirosaki University Graduate School of Medicine
– sequence: 5
  givenname: Saori
  surname: Ogasawara
  fullname: Ogasawara, Saori
  organization: Hirosaki University Graduate School of Medicine
– sequence: 6
  givenname: Chinatsu
  surname: Miura
  fullname: Miura, Chinatsu
  organization: Hirosaki University Graduate School of Medicine
– sequence: 7
  givenname: Takanori
  surname: Sasaki
  fullname: Sasaki, Takanori
  organization: Hirosaki University Graduate School of Medicine
– sequence: 8
  givenname: Masaki
  surname: Ryuzaki
  fullname: Ryuzaki, Masaki
  organization: Hirosaki University Graduate School of Medicine
– sequence: 9
  givenname: Soroku
  surname: Yagihashi
  fullname: Yagihashi, Soroku
  organization: Hirosaki University Graduate School of Medicine
– sequence: 10
  givenname: Hiroki
  orcidid: 0000-0003-2920-582X
  surname: Mizukami
  fullname: Mizukami, Hiroki
  email: hirokim@hirosaki‐u.ac.jp
  organization: Hirosaki University Graduate School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39453752$$D View this record in MEDLINE/PubMed
BookMark eNp1ks9uFSEUxompsbfVhS9gSNzoYlpgYP6sjLmpbU1TN7omDBy83MzACEyb-xB9Z7G3bdSkLA6L78d3PnLOETrwwQNCbyk5oeWcbr0-oQ2rxQu0orylFaeiP0ArQhirasLZITpKaUsIbXhDX6HDuueibgVbobuL3Qwxg08ueOwSVikF7VQGg29d3uC8ARzBLDrfAx7D7AzESY04lTJi64YIqSgGZijF53GHg8VpiYXxEG-giHZU06QePXJpihk2Tg2QnS7ssAWd02v00qoxwZuH-xj9-HL2fX1RXX07v1x_vqo0J1xUPbPGdoL2qhU9H2zLQVgGqjaN6nqmxdBaA51lFlTfWGiZqY2xWtgGLJihPkaf9r7zMkxgdAldwso5uknFnQzKyX8V7zbyZ7iRlHak46IpDh8eHGL4tUDKcnJJwzgqD2FJsqaM9GU2jBT0_X_oNizRl_8VqiUt44KyQr37O9JTlsdRFeDjHtAxpBTBPiGUyD9rIMsayPs1KOzpnr11I-yeB-XX6_X-xW-25bgb
Cites_doi 10.2337/dc09‐0554
10.1093/ajh/hpz058
10.1189/jlb.0512231
10.3390/ijms22010094
10.1111/j.1742‐7843.2011.00758.x
10.1016/j.neulet.2004.03.014
10.3390/ijms21218306
10.1293/tox.2020‐0003
10.1002/dmr.5610110304
10.1002/mus.25098
10.1007/s12026‐014‐8548‐6
10.4103/1673‐5374.253510
10.1242/dmm.033647
10.1177/000331977102200904
10.1080/14397595.2020.1830484
10.1016/j.nbd.2013.07.019
10.1111/j.1365‐2362.2010.02430.x
10.1016/S0140‐6736(98)02478‐7
10.1212/wnl.37.1.20
10.1016/j.nbd.2021.105392
10.1016/j.nbd.2022.105839
10.1056/NEJMoa032782
10.4049/jimmunol.1700373
10.1186/1742‐2094‐10‐64
10.1016/j.neuron.2017.02.005
10.1172/jci.insight.160555
10.1136/jcp.38.9.1030
10.1136/bmjdrc‐2020‐001739
10.1016/j.metabol.2020.154232
10.1002/(SICI)1097‐4598(199606)19:6<722::AID‐MUS6>3.0.CO;2‐C
10.1016/j.pain.2012.01.021
10.1007/s00401‐012‐1012‐6
10.1016/B978‐0‐444‐53480‐4.00001‐1
10.2337/diab.40.9.1090
10.1093/brain/awr228
10.1093/braincomms/fcaa168
10.1161/HYPERTENSIONAHA.111.174474
10.1007/s00401‐015‐1482‐4
10.1136/bmj.317.7160.703
10.1097/01.mnh.0000203189.57513.76
10.2337/diab.46.4.665
10.1212/wnl.60.1.108
10.1002/1520‐7560(200009/10)16:5<354::aid‐dmrr149>3.0.co;2‐h
10.1080/1028415X.2024.2383082
10.1007/BF00505180
10.1093/braincomms/fcae103
10.1212/NXI.0000000000001111
10.1111/j.1365‐2249.2005.02934.x
10.1007/s11892‐016‐0727‐5
10.1186/s13098‐015‐0005‐8
ContentType Journal Article
Copyright 2024 The Author(s). published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.
2024 The Author(s). Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.
2024. This work is published under Creative Commons Attribution – Non-Commercial – No Derivatives License~http://creativecommons.org/licenses/by-nc-nd/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 The Author(s). published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.
– notice: 2024 The Author(s). Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.
– notice: 2024. This work is published under Creative Commons Attribution – Non-Commercial – No Derivatives License~http://creativecommons.org/licenses/by-nc-nd/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QR
7TK
7U7
7U9
8FD
C1K
FR3
H94
P64
7X8
5PM
DOI 10.1111/jnc.16235
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Chemoreception Abstracts
Neurosciences Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Toxicology Abstracts
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef
Virology and AIDS Abstracts

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
DocumentTitleAlternate Wang et al
EISSN 1471-4159
EndPage n/a
ExternalDocumentID PMC11808456
39453752
10_1111_jnc_16235
JNC16235
Genre researchArticle
Journal Article
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29L
2WC
31~
33P
36B
3SF
4.4
41~
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAYJJ
AAZKR
ABCQN
ABCUV
ABEML
ABIVO
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOD
ACGOF
ACIWK
ACMXC
ACNCT
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FZ0
G-S
G.N
GAKWD
GODZA
GX1
H.X
HF~
HGLYW
HH5
HVGLF
HZI
HZ~
IH2
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PKN
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
TWZ
UB1
V8K
VH1
W8V
W99
WBKPD
WIH
WIJ
WIK
WIN
WNSPC
WOHZO
WOW
WQJ
WRC
WUP
WXI
WXSBR
WYISQ
X7M
XG1
XJT
YFH
YNH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QR
7TK
7U7
7U9
8FD
C1K
FR3
H94
P64
7X8
5PM
ID FETCH-LOGICAL-c4045-92fdf8519a7594bf74e5f2ea3d6a892c5b7fde8f2fea96fe72d3ddfc5f6efedb3
IEDL.DBID DR2
ISSN 0022-3042
1471-4159
IngestDate Thu Aug 21 18:28:19 EDT 2025
Fri Jul 11 03:18:40 EDT 2025
Sat Jul 12 03:05:14 EDT 2025
Mon Jul 21 05:58:09 EDT 2025
Tue Jul 01 04:41:08 EDT 2025
Tue Feb 25 10:00:12 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords macrophages
diabetic polyneuropathy
IENFD
autopsy
hypertension
Language English
License Attribution-NonCommercial-NoDerivs
2024 The Author(s). Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4045-92fdf8519a7594bf74e5f2ea3d6a892c5b7fde8f2fea96fe72d3ddfc5f6efedb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-2920-582X
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.16235
PMID 39453752
PQID 3170724512
PQPubID 31528
PageCount 16
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11808456
proquest_miscellaneous_3120911120
proquest_journals_3170724512
pubmed_primary_39453752
crossref_primary_10_1111_jnc_16235
wiley_primary_10_1111_jnc_16235_JNC16235
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2025
PublicationDateYYYYMMDD 2025-02-01
PublicationDate_xml – month: 02
  year: 2025
  text: February 2025
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
– name: Hoboken
PublicationTitle Journal of neurochemistry
PublicationTitleAlternate J Neurochem
PublicationYear 2025
Publisher Blackwell Publishing Ltd
John Wiley and Sons Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: John Wiley and Sons Inc
References 2004; 362
2022; 173
2012; 124
1997; 46
2019; 14
1998; 317
2017; 198
2011; 58
2014; 62
1998; 352
1987; 37
2020; 8
2015; 130
2021; 31
2020; 2
2000; 16
1989; 32
2005; 142
2024; 6
2013; 10
1991; 40
2014; 59
2021; 155
2024; 25
2014; 126
2021; 9
1971; 22
1996; 19
2005; 352
2019; 32
1995; 11
2006; 15
2016; 54
2020; 107
2020; 33
2016; 16
2015; 7
2011; 134
2012; 92
2012; 153
2012; 110
2009; 32
2017; 93
2022; 7
2011; 41
2020; 22
2020; 21
2003; 60
2018; 11
1985; 38
e_1_2_13_24_1
e_1_2_13_49_1
e_1_2_13_26_1
e_1_2_13_47_1
e_1_2_13_20_1
e_1_2_13_45_1
e_1_2_13_22_1
e_1_2_13_43_1
e_1_2_13_8_1
e_1_2_13_41_1
e_1_2_13_6_1
e_1_2_13_17_1
e_1_2_13_19_1
e_1_2_13_13_1
e_1_2_13_36_1
e_1_2_13_15_1
e_1_2_13_38_1
e_1_2_13_32_1
e_1_2_13_11_1
e_1_2_13_34_1
e_1_2_13_51_1
e_1_2_13_30_1
e_1_2_13_4_1
e_1_2_13_2_1
e_1_2_13_29_1
e_1_2_13_25_1
e_1_2_13_48_1
e_1_2_13_27_1
e_1_2_13_46_1
e_1_2_13_21_1
e_1_2_13_44_1
e_1_2_13_23_1
e_1_2_13_42_1
e_1_2_13_9_1
e_1_2_13_40_1
e_1_2_13_7_1
e_1_2_13_18_1
e_1_2_13_39_1
e_1_2_13_14_1
e_1_2_13_35_1
e_1_2_13_16_1
e_1_2_13_37_1
e_1_2_13_10_1
e_1_2_13_31_1
e_1_2_13_12_1
e_1_2_13_33_1
e_1_2_13_50_1
e_1_2_13_5_1
e_1_2_13_3_1
e_1_2_13_28_1
References_xml – volume: 38
  start-page: 1030
  issue: 9
  year: 1985
  end-page: 1038
  article-title: Small vessel disease in progressive diabetic neuropathy associated with good metabolic control
  publication-title: Journal of Clinical Pathology
– volume: 142
  start-page: 481
  issue: 3
  year: 2005
  end-page: 489
  article-title: Macrophage activation switching: An asset for the resolution of inflammation
  publication-title: Clinical and Experimental Immunology
– volume: 32
  start-page: 92
  issue: 2
  year: 1989
  end-page: 102
  article-title: Microangiopathy in human diabetic neuropathy: Relationship between capillary abnormalities and the severity of neuropathy
  publication-title: Diabetologia
– volume: 16
  start-page: 29
  issue: 3
  year: 2016
  article-title: Inflammation as a therapeutic target for diabetic neuropathies
  publication-title: Current Diabetes Reports
– volume: 93
  start-page: 1296
  issue: 6
  year: 2017
  end-page: 1313
  article-title: New horizons in diabetic neuropathy: Mechanisms, bioenergetics, and pain
  publication-title: Neuron
– volume: 153
  start-page: 982
  issue: 5
  year: 2012
  end-page: 989
  article-title: Epidermal Langerhans cells in small fiber neuropathies
  publication-title: Pain
– volume: 352
  start-page: 1978
  issue: 9145
  year: 1998
  end-page: 1981
  article-title: Effect of angiotensin‐converting‐enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: Randomised double‐blind controlled trial
  publication-title: Lancet
– volume: 126
  start-page: 3
  year: 2014
  end-page: 22
  article-title: Epidemiology of polyneuropathy in diabetes and prediabetes
  publication-title: Handbook of Clinical Neurology
– volume: 22
  issue: 1
  year: 2020
  article-title: Pathogenesis and molecular treatment strategies of diabetic neuropathy collateral glucose‐utilizing pathways in diabetic polyneuropathy
  publication-title: International Journal of Molecular Sciences
– volume: 32
  start-page: 1896
  issue: 10
  year: 2009
  end-page: 1900
  article-title: Large‐fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors
  publication-title: Diabetes Care
– volume: 92
  start-page: 1177
  issue: 6
  year: 2012
  end-page: 1186
  article-title: The mannose receptor
  publication-title: Journal of Leukocyte Biology
– volume: 32
  start-page: 796
  issue: 8
  year: 2019
  end-page: 803
  article-title: Hypertension contributes to neuropathy in patients with type 1 diabetes
  publication-title: American Journal of Hypertension
– volume: 173
  year: 2022
  article-title: The diversity and abundance of gut microbiota are associated with the pain sensation threshold in the Japanese population
  publication-title: Neurobiology of Disease
– volume: 198
  start-page: 3775
  issue: 10
  year: 2017
  end-page: 3789
  article-title: A consensus definitive classification of scavenger receptors and their roles in health and disease
  publication-title: Journal of Immunology
– volume: 15
  start-page: 152
  issue: 2
  year: 2006
  end-page: 158
  article-title: Inflammation in hypertension
  publication-title: Current Opinion in Nephrology and Hypertension
– volume: 46
  start-page: 665
  issue: 4
  year: 1997
  end-page: 670
  article-title: Hypertension as a risk factor for diabetic neuropathy: A prospective study
  publication-title: Diabetes
– volume: 134
  start-page: 3222
  issue: Pt 11
  year: 2011
  end-page: 3235
  article-title: The identification of gene expression profiles associated with progression of human diabetic neuropathy
  publication-title: Brain
– volume: 60
  start-page: 108
  issue: 1
  year: 2003
  end-page: 111
  article-title: The spectrum of neuropathy in diabetes and impaired glucose tolerance
  publication-title: Neurology
– volume: 124
  start-page: 561
  issue: 4
  year: 2012
  end-page: 573
  article-title: Hypertension‐induced peripheral neuropathy and the combined effects of hypertension and diabetes on nerve structure and function in rats
  publication-title: Acta Neuropathologica
– volume: 37
  start-page: 20
  issue: 1
  year: 1987
  end-page: 28
  article-title: Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy
  publication-title: Neurology
– volume: 6
  issue: 2
  year: 2024
  article-title: Tryptophan metabolism and small fibre neuropathy: A correlation study
  publication-title: Brain Communication
– volume: 7
  start-page: 9
  year: 2015
  article-title: Association of chronic diabetes and hypertension in sural nerve morphometry: An experimental study
  publication-title: Diabetology and Metabolic Syndrome
– volume: 130
  start-page: 605
  issue: 5
  year: 2015
  end-page: 618
  article-title: Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury
  publication-title: Acta Neuropathologica
– volume: 21
  issue: 21
  year: 2020
  article-title: Increased oxidative stress underlies abnormal pain threshold in a Normoglycemic Japanese population
  publication-title: International Journal of Molecular Sciences
– volume: 22
  start-page: 521
  year: 1971
  end-page: 522
  article-title: Hypertension and subclinical peripheral neuropathy
  publication-title: Angiology
– volume: 11
  issue: 4
  year: 2018
  article-title: CD40‐mediated HIF‐1α expression underlying microangiopathy in diabetic nerve pathology
  publication-title: Disease Models & Mechanisms
– volume: 10
  year: 2013
  article-title: Neurogenic factor‐induced Langerhans cell activation in diabetic mice with mechanical allodynia
  publication-title: Journal of Neuroinflammation
– volume: 107
  year: 2020
  article-title: Beneficial effects of combination therapy of canagliflozin and teneligliptin on diabetic polyneuropathy and β‐cell volume density in spontaneously type 2 diabetic Goto‐Kakizaki rats
  publication-title: Metabolism
– volume: 33
  start-page: 161
  issue: 3
  year: 2020
  end-page: 169
  article-title: Superimposition of hypertension on diabetic peripheral neuropathy affects small unmyelinated sensory nerves in the skin and myelinated tibial and sural nerves in rats with alloxan‐induced type 1 diabetes
  publication-title: Journal of Toxicologic Pathology
– volume: 11
  start-page: 193
  issue: 3
  year: 1995
  end-page: 225
  article-title: Pathology and pathogenetic mechanisms of diabetic neuropathy
  publication-title: Diabetes/Metabolism Reviews
– volume: 16
  start-page: 354
  issue: 5
  year: 2000
  end-page: 363
  article-title: Insulin receptor in rat peripheral nerve: Its localization and alternatively spliced isoforms
  publication-title: Diabetes/Metabolism Research and Reviews
– volume: 40
  start-page: 1090
  issue: 9
  year: 1991
  end-page: 1099
  article-title: Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor
  publication-title: Diabetes
– volume: 362
  start-page: 131
  year: 2004
  end-page: 135
  article-title: Morphological and conduction changes in the sciatic nerve of spontaneously hypertensive rats
  publication-title: Neuroscience Letters
– volume: 58
  start-page: 776
  issue: 5
  year: 2011
  end-page: 783
  article-title: DEMAND study investigators. Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: The delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial
  publication-title: Hypertension
– volume: 25
  start-page: 1
  year: 2024
  end-page: 11
  article-title: Moderate cryptoxanthin intake correlates with maintenance of a proper PINT index in a general Japanese population
  publication-title: Nutritional Neuroscience
– volume: 317
  start-page: 703
  issue: 7160
  year: 1998
  end-page: 713
  article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK prospective diabetes study group
  publication-title: BMJ
– volume: 14
  start-page: 1335
  issue: 8
  year: 2019
  end-page: 1342
  article-title: Role of macrophages in peripheral nerve injury and repair
  publication-title: Neural Regeneration Research
– volume: 41
  start-page: 442
  issue: 4
  year: 2011
  end-page: 450
  article-title: Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats
  publication-title: European Journal of Clinical Investigation
– volume: 7
  issue: 23
  year: 2022
  article-title: RAGE activation in macrophages and development of experimental diabetic polyneuropathy
  publication-title: JCI Insight
– volume: 155
  year: 2021
  article-title: Inhibitory effects of xanthine oxidase inhibitor, topiroxostat, on development of neuropathy in db/db mice
  publication-title: Neurobiology of Disease
– volume: 54
  start-page: 756
  issue: 4
  year: 2016
  end-page: 762
  article-title: Neuropathy in the spontaneously hypertensive rat: An electrophysiological and histological study
  publication-title: Muscle & Nerve
– volume: 31
  start-page: 849
  issue: 4
  year: 2021
  end-page: 855
  article-title: Detection of nerve enlargement with ultrasound and correlation with skin biopsy findings in painful sensory neuropathy associated with Sjögren's syndrome
  publication-title: Modern Rheumatology
– volume: 9
  issue: 1
  year: 2021
  article-title: Analysis of macrophages and peptidergic fibers in the skin of patients with painful diabetic polyneuropathy
  publication-title: Neurology Neuroimmunology and Neuroinflammation
– volume: 110
  start-page: 49
  issue: 1
  year: 2012
  end-page: 55
  article-title: Small artery remodelling in hypertension
  publication-title: Basic & Clinical Pharmacology & Toxicology
– volume: 352
  start-page: 341
  issue: 4
  year: 2005
  end-page: 350
  article-title: EURODIAB prospective complications study group. Vascular risk factors and diabetic neuropathy
  publication-title: The New England Journal of Medicine
– volume: 59
  start-page: 243
  issue: 1–3
  year: 2014
  end-page: 253
  article-title: The immune system and hypertension
  publication-title: Immunologic Research
– volume: 19
  start-page: 722
  issue: 6
  year: 1996
  end-page: 727
  article-title: Diabetic peripheral neuropathy: A clinicopathologic and immunohistochemical analysis of sural nerve biopsies
  publication-title: Muscle & Nerve
– volume: 8
  issue: 1
  year: 2020
  article-title: Lipopolysaccharide‐binding protein is a distinctive biomarker of abnormal pain threshold in the general Japanese population
  publication-title: BMJ Open Diabetes Research & Care
– volume: 2
  issue: 2
  year: 2020
  article-title: Role of glucosamine in development of diabetic neuropathy independent of the aldose reductase pathway
  publication-title: Brain Communication
– volume: 62
  start-page: 18
  year: 2014
  end-page: 30
  article-title: The adjuvant effect of hypertension upon diabetic peripheral neuropathy in experimental type 2 diabetes
  publication-title: Neurobiology of Disease
– ident: e_1_2_13_7_1
  doi: 10.2337/dc09‐0554
– ident: e_1_2_13_29_1
  doi: 10.1093/ajh/hpz058
– ident: e_1_2_13_20_1
  doi: 10.1189/jlb.0512231
– ident: e_1_2_13_22_1
  doi: 10.3390/ijms22010094
– ident: e_1_2_13_24_1
  doi: 10.1111/j.1742‐7843.2011.00758.x
– ident: e_1_2_13_45_1
  doi: 10.1016/j.neulet.2004.03.014
– ident: e_1_2_13_26_1
  doi: 10.3390/ijms21218306
– ident: e_1_2_13_28_1
  doi: 10.1293/tox.2020‐0003
– ident: e_1_2_13_47_1
  doi: 10.1002/dmr.5610110304
– ident: e_1_2_13_25_1
  doi: 10.1002/mus.25098
– ident: e_1_2_13_38_1
  doi: 10.1007/s12026‐014‐8548‐6
– ident: e_1_2_13_17_1
  doi: 10.4103/1673‐5374.253510
– ident: e_1_2_13_14_1
  doi: 10.1242/dmm.033647
– ident: e_1_2_13_3_1
  doi: 10.1177/000331977102200904
– ident: e_1_2_13_49_1
  doi: 10.1080/14397595.2020.1830484
– ident: e_1_2_13_6_1
  doi: 10.1016/j.nbd.2013.07.019
– ident: e_1_2_13_21_1
  doi: 10.1111/j.1365‐2362.2010.02430.x
– ident: e_1_2_13_19_1
  doi: 10.1016/S0140‐6736(98)02478‐7
– ident: e_1_2_13_48_1
  doi: 10.1212/wnl.37.1.20
– ident: e_1_2_13_41_1
  doi: 10.1016/j.nbd.2021.105392
– ident: e_1_2_13_42_1
  doi: 10.1016/j.nbd.2022.105839
– ident: e_1_2_13_43_1
  doi: 10.1056/NEJMoa032782
– ident: e_1_2_13_32_1
  doi: 10.4049/jimmunol.1700373
– ident: e_1_2_13_5_1
  doi: 10.1186/1742‐2094‐10‐64
– ident: e_1_2_13_8_1
  doi: 10.1016/j.neuron.2017.02.005
– ident: e_1_2_13_27_1
  doi: 10.1172/jci.insight.160555
– ident: e_1_2_13_44_1
  doi: 10.1136/jcp.38.9.1030
– ident: e_1_2_13_15_1
  doi: 10.1136/bmjdrc‐2020‐001739
– ident: e_1_2_13_11_1
  doi: 10.1016/j.metabol.2020.154232
– ident: e_1_2_13_50_1
  doi: 10.1002/(SICI)1097‐4598(199606)19:6<722::AID‐MUS6>3.0.CO;2‐C
– ident: e_1_2_13_2_1
  doi: 10.1016/j.pain.2012.01.021
– ident: e_1_2_13_10_1
  doi: 10.1007/s00401‐012‐1012‐6
– ident: e_1_2_13_51_1
  doi: 10.1016/B978‐0‐444‐53480‐4.00001‐1
– ident: e_1_2_13_37_1
  doi: 10.2337/diab.40.9.1090
– ident: e_1_2_13_13_1
  doi: 10.1093/brain/awr228
– ident: e_1_2_13_23_1
  doi: 10.1093/braincomms/fcaa168
– ident: e_1_2_13_33_1
  doi: 10.1161/HYPERTENSIONAHA.111.174474
– ident: e_1_2_13_4_1
  doi: 10.1007/s00401‐015‐1482‐4
– ident: e_1_2_13_46_1
  doi: 10.1136/bmj.317.7160.703
– ident: e_1_2_13_36_1
  doi: 10.1097/01.mnh.0000203189.57513.76
– ident: e_1_2_13_9_1
  doi: 10.2337/diab.46.4.665
– ident: e_1_2_13_40_1
  doi: 10.1212/wnl.60.1.108
– ident: e_1_2_13_39_1
  doi: 10.1002/1520‐7560(200009/10)16:5<354::aid‐dmrr149>3.0.co;2‐h
– ident: e_1_2_13_34_1
  doi: 10.1080/1028415X.2024.2383082
– ident: e_1_2_13_18_1
  doi: 10.1007/BF00505180
– ident: e_1_2_13_16_1
  doi: 10.1093/braincomms/fcae103
– ident: e_1_2_13_12_1
  doi: 10.1212/NXI.0000000000001111
– ident: e_1_2_13_31_1
  doi: 10.1111/j.1365‐2249.2005.02934.x
– ident: e_1_2_13_30_1
  doi: 10.1007/s11892‐016‐0727‐5
– ident: e_1_2_13_35_1
  doi: 10.1186/s13098‐015‐0005‐8
SSID ssj0016461
Score 2.46643
Snippet Diabetic polyneuropathy (DPN) is a multifactorial disease associated not only with hyperglycaemia but also with circulatory disturbances such as hypertension....
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e16235
SubjectTerms Adult
Aged
Autopsies
autopsy
Density
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - pathology
Diabetic Neuropathies - pathology
diabetic polyneuropathy
Diffusion barriers
Epidermis - innervation
Epidermis - pathology
Female
Humans
Hyperglycemia
Hypertension
Hypertension - complications
Hypertension - pathology
IENFD
Immune system
Infiltration
Inflammation
Inflammation - pathology
Inflammatory response
Macrophages
Macrophages - pathology
Male
Middle Aged
Nerve Fibers - pathology
Nerves
Original
Polyneuropathy
Sural nerve
Sural Nerve - pathology
Thickness
Title Hypertension is associated with the reduction in epidermal small fibres independently of sural nerve inflammation in type 2 diabetic subjects
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.16235
https://www.ncbi.nlm.nih.gov/pubmed/39453752
https://www.proquest.com/docview/3170724512
https://www.proquest.com/docview/3120911120
https://pubmed.ncbi.nlm.nih.gov/PMC11808456
Volume 169
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SXNpLH0kfTtOgllJ6cbBlyw96CkvDEmgopYEcCkaWR3TJVlvW3kPyH_qfOyM_yDYUSi_GoJEtWzOeT-PRNwBvrY6lyeMyNCmqMM0Qw0I1ZZiU2tiosJFB3o386TybX6Rnl-pyBz6Me2F6fogp4MaW4b_XbOC6bm8bOdlPTM6bN5hzrhYDoi8TdRTTZsUTUzhp5sAq5LN4xp7bvugOwLybJ3kbv3oHdPoIvo1D7_NOro43XX1sbv5gdfzPZ3sMDwdgKk56TXoCO-j2YP_E0aL8x7V4J3yqqI_B78H92Vgmbh9-zWklu_Z58CsnFq3Qw4RjIzjIKwhhijUTxHZewAnkorTkD5aipcNSWBoqtmIxFeTtltdiZUXLjCDCcUomNVpS3X6bJV-DI8dCij5yvDAkW3NAqX0KF6cfv87m4VDjgZSD0GRYSttYQn2lzlWZ1jYnlbESddJkuiilUXVuGyystKjLzGIum6RprFE2Q4tNnTyDXbdy-AIEYReaKVNYE5epok5I4K5QaFNTF0qZAN6Ms1397Kk8qmkJ5EzlX3gAh6MeVIM1txVhrCiXKWGjAF5PzfSe-eeKdrjasIyM2HHIKIDnvdpMd0loPEmuqHexpVCTAHN8b7e4xXfP9c0MfQWB3ADee4X5-8irs_OZPzn4d9GX8EByPWOfhX4Iu916g68IZHX1EdyT6ecjb1O_AbYXKiQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VciiXAi3QQAGDEOKSKnHiPCQu1YpqKe0eUCv1gqLE8YgVixdtsofyH_jPzDgPdamQEJcokseJE89kPk_G3wC8wTKUOg1zX8dG-XFijJ-pOvejvNQYZBhow7uRz2fJ9DI-vVJXW_B-2AvT8UOMATe2DPe9ZgPngPRNKycDCsl7qztwlyt6uwXV55E8iomzwpErnHSz5xVyeTxD101vdAti3s6UvIlgnQs6uQ9fhsF3mSffjtZtdaR__sHr-L9P9wB2e2wqjjtleghbxu7B_rGldfn3a_FWuGxRF4bfg53JUCluH35NaTG7cqnwSyvmjSj7OTe14DivIJApVswR2zoBKwzXpSWXsBANHRYCaaymEfOxJm-7uBZLFA2TggjLWZnUiKS93U5LvgYHj4UUXfB4rkm24phS8wguTz5cTKZ-X-aB9IMApZ9LrJGAX16mKo8rTElrUJoyqpMyy6VWVYq1yVCiKfMETSrrqK5RK0wMmrqKHsO2XVpzAILgC02VzlCHeayokyF8lymDsa4ypbQHr4fpLn50bB7FuAqyunAv3IPDQRGK3qCbgmBWkMqY4JEHr8Zmes_8f6W0ZrlmGRmw75CBB086vRnvEtF4olRR72xDo0YBpvnebLHzr47um0n6MsK5HrxzGvP3kRens4k7efrvoi9hZ3pxflacfZx9egb3JJc3dknph7DdrtbmOWGutnrhTOs3G78taA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6NIcFe-LExKAwwCCFeMiVOnDjiaeqoyoAKISbtASlKbJ-oVtypSR_G_8D_zNn5oZUJCfFSVfI5dePv4s-X83cAr7CMuMqiPFCJEUGSGhNIofMgzkuFocRQGXca-dMsnZ4mJ2fibAve9mdhWn2IIeDmPMM_r52DX2i86uTkPxEt3uIG3EzSUDpIH38ZtKOcblY0SIUTNDtZIZ_G03fdXIyuMczriZJXCaxfgSZ34Vs_9jbx5Pxw3VSH6ucfso7_-efuwZ2OmbKjFkr3YcvYXdg7srQr_3HJXjOfK-qD8Ltwe9zXiduDX1Payq58IvzSsnnNym7GjWYuysuIYrKVU4htvIFlxlWlpQVhwWr6WDCkoZqazYeKvM3iki2R1U4ShFmXk0mNSNhtz1m6a7jQMeOsDR3PFdlWLqJUP4DTybuv42nQFXkgdBCdDHKOGon25WUm8qTCjDCD3JSxTkuZcyWqDLWRyNGUeYom4zrWGpXA1KDRVbwP23ZpzSNgRF5oppREFeWJoE6G2J0UBhNVSSHUCF72s11ctFoexbAHsqrwN3wEBz0Ois6d64JIVpjxhMjRCF4MzXSf3duV0prl2tnw0K0cPBzBwxY2w6_ENJ44E9RbbgBqMHAi35stdv7di307iT5JLHcEbzxg_j7y4mQ29l8e_7vpc7j1-XhSfHw_-_AEdrirbewz0g9gu1mtzVMiXE31zDvWb6SsLCA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypertension+is+associated+with+the+reduction+in+epidermal+small+fibres+independently+of+sural+nerve+inflammation+in+type+2+diabetic+subjects&rft.jtitle=Journal+of+neurochemistry&rft.au=Wang%2C+Zhenchao&rft.au=Kushibiki%2C+Hanae&rft.au=Tarusawa%2C+Takefusa&rft.au=Osonoi%2C+Sho&rft.date=2025-02-01&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=169&rft.issue=2&rft.epage=n%2Fa&rft_id=info:doi/10.1111%2Fjnc.16235&rft.externalDBID=10.1111%252Fjnc.16235&rft.externalDocID=JNC16235
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon